BUDGET IMPACT OF NIRAPARIB AS MAINTENANCE TREATMENT FOR MEDICARE PATIENTS WITH RECURRENT OVARIAN, FALLOPIAN TUBE, OR PRIMARY PERITONEAL CANCER WHO ARE IN COMPLETE OR PARTIAL RESPONSE TO PLATINUM-BASED CHEMOTHERAPY

被引：0
|
作者：
Neeser, K. [1 ]
O'Neil, W. M. [1 ]
Stern, L. [1 ]
机构：
[1] Analyt Laser, New York, NY USA
来源：
VALUE IN HEALTH | 2018年 / 21卷
关键词：
D O I：
10.1016/j.jval.2018.04.129
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCN51
引用
收藏
页码：S21 / S21
页数：1
相关论文
共 50 条
  • [31] Role of salvage cytoreductive surgery in the treatment of patients with recurrent ovarian cancer after platinum-based chemotherapy
    Matsumoto, Aya
    Higuchi, Toshihiro
    Yura, Shigeo
    Mandai, Masaki
    Kariya, Masatoshi
    Takakura, Kenji
    Fujii, Shingo
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, 2006, 32 (06) : 580 - 587
  • [32] Phase II evaluation of topotecan and navelbine in patients with recurrent ovarian, fallopian tube or primary peritoneal cancer
    Herzog, Thomas J.
    Powell, Matthew A.
    Rader, Janet S.
    Gibb, Randall K.
    Lippmann, Lynne
    Coleman, Robert L.
    Mutch, David G.
    GYNECOLOGIC ONCOLOGY, 2008, 111 (03) : 467 - 473
  • [33] Tertiary cytoreduction in patients with recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer: An updated series
    Shih, K. K.
    Chi, D. S.
    Barakat, R. R.
    Leitao, M. M., Jr.
    GYNECOLOGIC ONCOLOGY, 2010, 117 (02) : 330 - 335
  • [34] A phase II study of chemoimmunotherapy for the treatment of recurrent, platinum-sensitive ovarian, fallopian tube, and primary peritoneal cancers
    Schmeler, K. M.
    Vadhan-Raj, S.
    Ramirez, P. T.
    Cohen, L.
    Garcia, M. E.
    Bassett, R. I.
    Iyer, R. B.
    Mueller, P.
    Levenback, C. L.
    Wolf, J. K.
    Gershenson, D. M.
    Freedman, R. S.
    GYNECOLOGIC ONCOLOGY, 2008, 108 (03) : S112 - S112
  • [35] Tertiary cytoreduction in patients with recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer: An updated series
    Shih, K. K.
    Chi, D. S.
    Barakat, R. R.
    Leitao, M. M.
    GYNECOLOGIC ONCOLOGY, 2009, 112 (02) : S155 - S155
  • [36] Survival after maximum effort cytoreductive surgery and platinum-based chemotherapy in patients with epithelial ovarian cancer, fallopian tube carcinoma and primary peritoneal carcinomatosis: Experience of a Public University Hospital in Spain
    Khosravi-Shahi, Parham
    Cabezon-Gutierrez, Luis
    Custodio-Cabello, Sara
    GACETA MEXICANA DE ONCOLOGIA, 2019, 18 (01): : 13 - 21
  • [37] Effects of PARP Inhibitors on Subsequent Platinum-Based Chemotherapy in Patients with Recurrent Ovarian Cancer
    Kokabu, Tetsuya
    Tarumi, Yosuke
    Aoki, Kota
    Okamura, Ayaka
    Aoyama, Kohei
    Kataoka, Hisashi
    Yoriki, Kaori
    Mori, Taisuke
    CANCERS, 2024, 16 (15)
  • [38] A phase II study of the combination chemotherapy of bevacizumab and gemcitabine in women with platinum-resistant recurrent epithelial ovarian, primary peritoneal, or fallopian tube cancer
    Nagao, Shoji
    Kogiku, Ai
    Suzuki, Kazuhiro
    Shibutani, Takashi
    Yamamoto, Kasumi
    Jimi, Tomoatsu
    Kitai, Miho
    Shiozaki, Takaya
    Matsuoka, Kazuko
    Yamaguchi, Satoshi
    JOURNAL OF OVARIAN RESEARCH, 2020, 13 (01)
  • [39] A phase II study of the combination chemotherapy of bevacizumab and gemcitabine in women with platinum-resistant recurrent epithelial ovarian, primary peritoneal, or fallopian tube cancer
    Shoji Nagao
    Ai Kogiku
    Kazuhiro Suzuki
    Takashi Shibutani
    Kasumi Yamamoto
    Tomoatsu Jimi
    Miho Kitai
    Takaya Shiozaki
    Kazuko Matsuoka
    Satoshi Yamaguchi
    Journal of Ovarian Research, 13
  • [40] RANDOMIZED PHASE III TRIAL ON NIRAPARIB-TSR-042 (DOSTARLIMAB) VERSUS PHYSICIAN'S CHOICE CHEMOTHERAPY IN RECURRENT OVARIAN, FALLOPIAN TUBE, PRIMARY PERITONEAL CANCER PLATINUM RESISTANT PATIENTS: NITCHE TRIAL(MITO 33)
    Salutari, Vanda
    Musacchio, Lucia
    Pignata, Sandro
    Braicu, Elena Ioana
    Cibula, David
    Colombo, Nicoletta
    Frenel, Jean-Sebastien
    Zagouri, Flora
    Camarda, Floriana
    Giolitto, Serena
    Giudice, Elena
    Perri, Maria Teresa
    Scambia, Giovanni
    Lorusso, Domenica
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2022, 32 : A240 - A240
12345